GGrantIndex
Sort

53,477 grants matching addiction

Finding the projection-specific dopaminergic synaptic organizers

$587,151
Hisashi Umemori · Boston Children'S Hospital · R01 · FY2020 · DA

Finding the projection-specific dopaminergic synaptic organizers

$587,151
Hisashi Umemori · Boston Children'S Hospital · R01 · FY2021 · DA

SRI International (SRI) Clinical Trial Site and Mechanistic Study

$587,085
Gary E Swan · University Of Pennsylvania · U01 · FY2012 · DA

Evidence Based Sober Living Houses: A Multi-level Analysis

$587,039
Douglas L Polcin · Public Health Institute · R01 · FY2020 · DA

Opioid Use Trajectories and HIV Risk among Young Adults in Ohio

$587,032
Robert G. Carlson · Wright State University · R01 · FY2012 · DA

New Glycinergic Modulators as Potent Painkillers without Negative Psychoactive Effects

$587,020
Yan Xu · University Of Pittsburgh At Pittsburgh · UG3 · FY2019 · NS

Neurobiology of Alcohol and Inhalant Abuse

$586,999
Toni Shippenberg · National Institute On Drug Abuse · ZIA · FY2011 · DA

Modeling Goal-Oriented Versus Habitual Drug-Seeking and Taking In Rodents

$586,999
Toni Shippenberg · National Institute On Drug Abuse · ZIA · FY2011 · DA

Tobacco Craving and Cigarette Reinforcement in Normal and Schizophrenic Smokers

$586,938
Stephen Heishman · National Institute On Drug Abuse · ZIA · FY2010 · DA

Developing ASCL1 and NeuroD1 lineage oncogene targeted therapy for small cell lung cancer

$586,917
John D Minna · Ut Southwestern Medical Center · U01 · FY2019 · CA

Multisite Controlled Trial of Cocaine Vaccine (1of 6) Lead Site/ Houston Treatmen

$586,910
Thomas Richard Kosten · Baylor College Of Medicine · R01 · FY2011 · DA

Molecular genetics of sensory modulation of motor programs

$586,885
Niels Ringstad · New York University School Of Medicine · R35 · FY2022 · GM

Molecular genetics of sensory modulation of motor programs

$586,885
Niels Ringstad · New York University School Of Medicine · R35 · FY2023 · GM

Molecular genetics of sensory modulation of motor programs

$586,885
Niels Ringstad · New York University School Of Medicine · R35 · FY2025 · GM

Molecular genetics of sensory modulation of motor programs

$586,885
Niels Ringstad · New York University School Of Medicine · R35 · FY2024 · GM

The neuroimmune model of excessive alcohol consumption: Transition to Alcohol Use Disorder

$586,875
Igor Ponomarev · University Of Texas At Austin · R01 · FY2018 · AA

NOVEL COCAINE PHARMACOTHERAPIES: LAB STUDIES

$586,839
Columbia University Health Sciences · R01 · FY2002 · DA

Testing the Leadership and Organizational Change for Implementation (LOCI) Intervention in Substance Abuse Treatment Programs

$586,816
Gregory Aarons · University Of California, San Diego · R01 · FY2016 · DA

Effects of Stereotype Threat on Impulsivity and Its Relation to Alcohol Use in African Americans: An fMRI Study

$586,714
Uraina S Clark · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · AA

DYNAMICS OF SIGNAL TRANSDUCTION IN NEURONS

$586,649
Mark H Ellisman · University Of California, San Diego · R01 · FY2016 · NS

Zonisamide for the Treatment of Alcohol Use Disorder in the Addiction Neuroclinical Assessment Framework

$586,597
Sterling M McPherson · Washington State University · R01 · FY2024 · AA

Neurobehavioral Mechanisms of Choices to Smoke Cannabis in Cannabis Use Disorder

$586,571
Suzette M Evans · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R01 · FY2019 · DA

Neurobehavioral Mechanisms of Choices to Smoke Cannabis in Cannabis Use Disorder

$586,571
Suzette M Evans · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R01 · FY2020 · DA

Neurobehavioral Mechanisms of Choices to Smoke Cannabis in Cannabis Use Disorder

$586,571
Suzette M Evans · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R01 · FY2018 · DA

Neurobehavioral Mechanisms of Choices to Smoke Cannabis in Cannabis Use Disorder

$586,571
Suzette M Evans · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R01 · FY2021 · DA